6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-γ activators
摘要:
Various 6-aryl-3-cyano/methoxycarbonyl-4-methylsulfanyl-2H-pyran-2-ones have been synthesized as a potential substitute of 2,4-thiazolidinedione head group to express potent PPAR-gamma transactivation response. Some of the screened compounds have shown promising PPAR-gamma agonistic activity. (c) 2005 Elsevier Ltd. All rights reserved.
Novel Inhibitors of Histone Deacetylase for the Treatment of Disease
申请人:Malecha James
公开号:US20080194681A1
公开(公告)日:2008-08-14
Disclosed herein are carbonyl compounds of Formula: (I) as described herein. Compounds as modulators of his-tone deacetylase (HDAC), pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
NOVEL INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE
申请人:Kalypsys, Inc.
公开号:EP1819669A2
公开(公告)日:2007-08-22
[EN] NOVEL INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE<br/>[FR] NOUVEAUX INHIBITEURS DE L'HISTONE DEACETYLASE PERMETTANT DE TRAITER UNE MALADIE
申请人:KALYPSYS INC
公开号:WO2006063294A2
公开(公告)日:2006-06-15
[EN] Disclosed herein are carbonyl compounds of Formula: (I) as described herein. Compounds as modulators of histone deacetylase (HDAC), pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed. [FR] L'invention concerne des composés carbonyles représentés par la formule (I). L'invention concerne également des composés utilisés comme modulateurs de l'histone déacétylase (HDAC), des compositions pharmaceutiques comprenant lesdits composés et des méthodes permettant de traiter une maladie à l'aide de ces composés.
WO2006/63294
申请人:——
公开号:——
公开(公告)日:——
6-Aryl-4-methylsulfanyl-2H-pyran-2-one-3-carbonitriles as PPAR-γ activators
作者:Ashoke Sharon、Ramendra Pratap、Rit Vatsyayan、Prakas R. Maulik、Uma Roy、Atul Goel、Vishnu Ji Ram
DOI:10.1016/j.bmcl.2005.05.031
日期:2005.7
Various 6-aryl-3-cyano/methoxycarbonyl-4-methylsulfanyl-2H-pyran-2-ones have been synthesized as a potential substitute of 2,4-thiazolidinedione head group to express potent PPAR-gamma transactivation response. Some of the screened compounds have shown promising PPAR-gamma agonistic activity. (c) 2005 Elsevier Ltd. All rights reserved.